Currently set to Index
Currently set to Follow
search
ask age2b
CART 0

A pilot multi-centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers

By AGE2B team
August 26, 2021
0
0

Paul D Hayes 1, Keith G Harding 2, Susan M Johnson 3, Charles McCollum 4, Luc Téot 5, Kevin Mercer 6, David Russell

Main idea: This study indicates that application of autologous skin cell suspension + compression accelerates healing in large venous ulcers.

Abstract

Venous leg ulcers (VLUs) have a significant impact on approximately 3% of the adult population worldwide. The standard care for VLUs is compression therapy, with a significant number of ulcers failing to heal. Wound size is a risk factor for non-healing, especially for ulcers up to 80cm2 in size. A randomised, multicentre, prospective, randomised trial evaluated the safety and effectiveness of autologous skin cell suspension (ASCS) combined with compression therapy. Additionally, subjects treated with ASCS + compression experienced a decrease in pain and an increase in HRQoL compared with the Control.

Source NIH

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.